MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Home>Markets

Diabetes

Livongo is Still Blowing Minds with Its Success
Livongo is Still Blowing Minds with Its Success
Mar 04, 2020
The company brought in about $50.2 million in revenue for 4Q19 compared to revenue in 4Q18 of $21.2 million. Livongo has a winning combination of artificial intelligence; patient empowerment; and diabetes management.
Senseonics Eyes Longer-Term CGM Sensor
Senseonics Eyes Longer-Term CGM Sensor
Feb 26, 2020
The company received FDA approval to have a subgroup of PROMISE study participants continue for a total of one year to gather feasibility data on the safety and accuracy of a 365-day Eversense sensor.
Medtronic Faces Class I Recall Over Insulin Pumps
Medtronic Faces Class I Recall Over Insulin Pumps
Feb 14, 2020
The Dublin-based company’s pumps were recalled because of a missing or broken retainer ring that helps lock the insulin cartridge into place. One death and 2,175 injuries are connected to the device.
DexCom's Preliminary Numbers Shine at J.P. Morgan
DexCom's Preliminary Numbers Shine at J.P. Morgan
Jan 14, 2020
DexCom presented strong preliminary financial results and gave an update on its highly anticipated G7 Continuous Glucose Monitor (CGM) sensor during the 38th annual J.P. Morgan Healthcare Conference.
Abbott Kicks in for Bigfoot's $45M Financing
Abbott Kicks in for Bigfoot's $45M Financing
Jan 13, 2020
The company is on track to submit its Bigfoot Unity diabetes management program for FDA clearance in 2020, and is targeting a product launch by the end of the year.
Load More